Collaborations, Competitor News, Data Partnership, Oncology

Real-World Data Show Unmet Need in KRAS p.G12C-Mutated Metastatic Colorectal Cancer

Treatment patterns are generally similar for patients with metastatic colorectal cancer (mCRC), whether or not they have KRAS p.G12C mutations, according to a real-world study published in The Oncologist.  The data also showed numerically shorter overall survival (OS) and real-world progression-free survival (rwPFS) among patients with KRAS p.G12C mutations. “These patients appear to have poor…

Competitor News

InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV

VANCOUVER, British Columbia and SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle…

Competitor News, Synthetic Data

MDClone Wins Second Consecutive “Best Healthcare Big Data Platform” Award in Annual MedTech Breakthrough Awards Program

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies May 05, 2022 08:00 AM Eastern Daylight Time BE’ER SHEVA, Israel–(BUSINESS WIRE)–MDClone, a leading data analytics and synthetic data company, today announced that for the second year in a row, the MDClone ADAMS Platform has been recognized as…

Collaborations, Government/Regulatory, Partner and Collaborator News

Palantir Selected for $90 million, 5-year HHS Contract Vehicle

May 04, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR), a leading builder of operating systems in use across the U.S. government, today announced it had been selected by the Department of Health and Human Services (HHS) for its 5-year “Solutioning with Holistic Analytics Restructured for the…

Competitor News, Pharma, RWE Study

Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022

Wednesday, May 04, 2022 – 07:00am NEW YORK, NY, May 4, 2022 – Pfizer Inc. (NYSE:PFE) announced today the presentation of real-world evidence demonstrating an associated benefit for patients treated with IBRANCE® (palbociclib) in combination with an aromatase inhibitor (AI), as compared to AI alone, in the first-line setting, at…

Competitor News, HR

Healthcare Technology Leader Joins Verantos′ Strategic Advisory Board

Frank Williams, co-founder and chairman of Evolent Health, is a value-based healthcare expert. PALO ALTO, Calif., May 4, 2022 /PRNewswire/ — Verantos, the market leader in high-validity real-world evidence generation, recently announced the appointment of Frank Williams to its strategic advisory board. Mr. Williams is the chairman and co-founder of Evolent Health and previously served…

Collaborations, Competitor News

Arcadia Partners with Datavant to Accelerate Biopharma Research

Datavant will enable connectivity to Arcadia’s de-identified electronic health record data; Arcadia’s diverse, rapidly growing data asset and comprehensive, longitudinal insights to drive innovations in patient care May 04, 2022 09:00 ET | Source: Datavant BOSTON and SAN FRANCISCO, May 04, 2022 (GLOBE NEWSWIRE) — Arcadia, the leading data analytics platform for…

Collaborations, Competitor News, Data Partnership, RWE Study

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Authors Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Kunzweiler C, Vu JD, Cheung HC , Duh MS  Received 6 November 2021 Accepted for publication 12 April 2022 Published 3 May 2022 Volume 2022:14 Pages 357—369 DOI https://doi.org/10.2147/CEOR.S346816 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof. Dr. Dean SmithDownload Article [PDF] Wendy Y Cheng,1 Sujata P Sarda,2 Nikita…